NARI vs. ICUI, CMD, NUVA, SILK, TFX, SOLV, GMED, PEN, GKOS, and MMSI
Should you be buying Inari Medical stock or one of its competitors? The main competitors of Inari Medical include ICU Medical (ICUI), Cantel Medical (CMD), NuVasive (NUVA), Silk Road Medical (SILK), Teleflex (TFX), Solventum (SOLV), Globus Medical (GMED), Penumbra (PEN), Glaukos (GKOS), and Merit Medical Systems (MMSI). These companies are all part of the "medical" sector.
ICU Medical (NASDAQ:ICUI) and Inari Medical (NASDAQ:NARI) are both mid-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their community ranking, dividends, valuation, profitability, institutional ownership, media sentiment, earnings, risk and analyst recommendations.
96.1% of ICU Medical shares are held by institutional investors. Comparatively, 91.0% of Inari Medical shares are held by institutional investors. 6.7% of ICU Medical shares are held by company insiders. Comparatively, 10.6% of Inari Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Inari Medical has lower revenue, but higher earnings than ICU Medical. Inari Medical is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.
In the previous week, Inari Medical had 25 more articles in the media than ICU Medical. MarketBeat recorded 27 mentions for Inari Medical and 2 mentions for ICU Medical. Inari Medical's average media sentiment score of 1.72 beat ICU Medical's score of 0.09 indicating that ICU Medical is being referred to more favorably in the media.
ICU Medical received 325 more outperform votes than Inari Medical when rated by MarketBeat users. However, 68.24% of users gave Inari Medical an outperform vote while only 64.48% of users gave ICU Medical an outperform vote.
ICU Medical has a net margin of -2.63% compared to ICU Medical's net margin of -4.54%. Inari Medical's return on equity of 5.38% beat ICU Medical's return on equity.
ICU Medical presently has a consensus price target of $123.00, indicating a potential upside of 9.65%. Inari Medical has a consensus price target of $65.71, indicating a potential upside of 35.02%. Given ICU Medical's higher probable upside, analysts plainly believe Inari Medical is more favorable than ICU Medical.
ICU Medical has a beta of 0.73, indicating that its share price is 27% less volatile than the S&P 500. Comparatively, Inari Medical has a beta of 1.02, indicating that its share price is 2% more volatile than the S&P 500.
Summary
ICU Medical and Inari Medical tied by winning 9 of the 18 factors compared between the two stocks.
Get Inari Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for NARI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NARI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Inari Medical Competitors List
Related Companies and Tools
